Hepatitis B Vaccine Triples the Risk of Autism in Infant Boys

As Dr. Mercola pointed out:

Now, hepatitis B is a rare, mainly blood-transmitted disease. In 1996 only 54 cases of the disease were reported to the CDC in the 0-1 age group. There were 3.9 million births that year, so the observed incidence of hepatitis B in the 0-1 age group was just 0.001 percent.

Meanwhile, in that same year VAERS received 1,080 total reports of adverse reactions from hepatitis B vaccine in the 0-1 age group, including 47 deaths!

Put in simpler terms: for every child that contracted hepatitis B there were 20 immunized babies that were reported to have severe complications. Let us also remember that only 10 percent of the reactions are ever reported, which means traditional medicine is harming about 200 children to protect one from hepatitis B!

and,

. . . hepatitis B is about as difficult to catch as AIDS. Namely, you nearly always need to have blood or sexual contact of some sort.

That is why the main risk factors are IV drug abusers and those who engage in sex with multiple partners.

In addition, vaccine-derived immunity is thought to be short lived. Up to 60 percent of persons who initially respond will lose detectable antibodies within 12 years. So that means that these vaccines will provide little to no protection to the real risks of acquiring hepatitis B, namely promiscuous sexual behavior and IV drug abuse.

http://articles.mercola.com/sites/articles/archive/2009/10/08/Hepatitis-B-Vaccine-Triples-the-Risk-of-Autism-in-Infant-Boys.aspx

Now, we also have the FDA approval for Gardasil for young boys.  Since it's primary protection would be against genital warts and HPV and it too will largely wear off early on, once again we have a vaccine to protect sexually promiscuous grade schoolers.

When it comes to vaccines, always follow the money trail. 

See:  Fobert F, Kennedy, Jr's Rolling Stone article about the vaccine industry's greed and cover up and my own article about mainstream support of vaccinations.

Add To Favorites!